Longitudinal data [36,37] have demonstrated that persistently elevated IL-6 levels are associated with excess mortality and decreased exercise tolerance, supporting its value as a prognostic biomarker in the management of COPD. The gene discussed is IL6; the disease is chronic obstructive pulmonary disease.